Metals — Toxic Elements, Urine, Random (Mosaic Diagnostics)

Lead is a non-essential divalent heavy metal with no known biological function. Following absorption via inhalation, ingestion, or dermal routes, lead distributes into three body compartments: blood (half-life approximately 35 days), soft tissues (weeks to months), and the skeletal system — where approximately 95% of total body lead burden is stored in bone, with a half-life of years to decades. Urinary lead excretion reflects labile soft-tissue and blood compartment lead, not skeletal burden. Lead is a potent competitive inhibitor of calcium, zinc, and iron in enzymatic reactions — disrupting haem synthesis, neurological function, and calcium-dependent cellular signalling through mechanistic substitution at divalent cation binding sites.

Lead is one of the most extensively studied environmental toxicants and has no safe level of exposure. Urinary lead elevation indicates ongoing exposure or mobilisation from soft-tissue stores and is used to monitor occupational exposure, assess recent environmental lead burden, and guide chelation monitoring. Random urine lead underestimates total body burden, as skeletal lead requires provocation (chelation challenge) to mobilise into urine. In functional and integrative medicine, urinary lead is assessed as part of multi-metal toxicant screening in patients presenting with fatigue, cognitive impairment, hypertension, peripheral neuropathy, or developmental concerns in children.

Urinary mercury predominantly reflects inorganic mercury and methylmercury demethylation products — the renal route is the primary excretory pathway for inorganic mercury, while methylmercury (from fish consumption) is excreted primarily in faeces via bile. Hair mercury and whole-blood mercury are superior markers for methylmercury assessment; urinary mercury is the preferred matrix for inorganic and elemental mercury exposure monitoring (dental amalgam, industrial exposure). Mercury has a high affinity for sulfhydryl groups, inhibiting selenoenzymes, thioredoxin reductase, and glutathione peroxidase, disrupting mitochondrial function and antioxidant defence.

Urinary mercury is assessed in the context of dental amalgam exposure, occupational mercury use (laboratories, chloralkali industry, artisanal gold mining), fish and seafood consumption pattern, and investigation of neurological, renal, immunological, or fatigue symptoms attributed to mercury burden in functional medicine practice. The clinical distinction between inorganic (urinary) and organic methylmercury (whole blood/hair) is critical — elevated urinary mercury with low blood mercury suggests inorganic/elemental exposure, while elevated blood or hair mercury with low urinary mercury suggests organic methylmercury from dietary fish as the primary source.

Arsenic exists in organic and inorganic forms with profoundly different toxicological profiles. Inorganic arsenic — trivalent arsenite (As³⁺) and pentavalent arsenate (As⁵⁺) — is the toxic species, derived from contaminated groundwater, rice, industrial exposure, and pressure-treated wood. Organic arsenobetaine, the predominant arsenic form in seafood, is essentially non-toxic and rapidly excreted in urine. Following inorganic arsenic absorption, the body sequentially methylates it to monomethylarsonic acid (MMA) and dimethylarsinic acid (DMA) via arsenic methyltransferase (AS3MT) — a detoxification pathway requiring folate, B12, and methionine as cofactors. Urinary speciation of MMA and DMA alongside inorganic arsenic fractions provides the full metabolic profile.

Inorganic arsenic is a Group 1 IARC carcinogen causally associated with bladder, lung, and skin cancers following chronic exposure. Urinary total arsenic without speciation is clinically misleading in patients with regular fish or seafood consumption. Practitioners ordering this panel in patients with high seafood intake should request inorganic arsenic speciation, advise abstinence from seafood for 48–72 hours prior to collection, or interpret total arsenic with explicit acknowledgement of the dietary arsenic contribution. In functional medicine, arsenic is assessed alongside other toxic metals in patients with unexplained fatigue, peripheral neuropathy, skin changes, or those with identified high-exposure sources (contaminated well water, rice-heavy diets).

Cadmium is a non-essential toxic metal with an exceptionally long biological half-life of 10–30 years, accumulating preferentially in the renal cortex and liver. Primary exposure routes are cigarette smoking (a major source — smokers have substantially higher cadmium burden than non-smokers), dietary intake from cereals, leafy vegetables, and shellfish grown in cadmium-contaminated soil, and occupational exposure in battery manufacturing, smelting, and pigment production. Urinary cadmium primarily reflects renal tubular cadmium burden following long-term accumulation rather than recent acute exposure, as renal tubular damage from cadmium causes increased urinary cadmium spillover — making urinary cadmium a dual indicator of total body burden and early nephrotoxic effect.

Chronic cadmium accumulation produces proximal renal tubular dysfunction (Fanconi syndrome pattern — phosphaturia, glucosuria, aminoaciduria), progressive renal insufficiency, and bone demineralisation through direct osteotoxic and secondary renal calcium/phosphate wasting effects. Cadmium is a Group 1 IARC carcinogen, associated primarily with lung cancer in occupationally exposed populations and bladder and kidney cancer in the general population. In integrative medicine, smoking history is the single most important interpretive context for urinary cadmium results.

Aluminum is ubiquitous in the environment and diet — present in antacids, antiperspirants, food additives (aluminium silicate, aluminium-containing baking powder), cookware, and municipal drinking water. In individuals with normal renal function, the kidneys efficiently excrete aluminum absorbed from the GI tract, limiting systemic accumulation. Renal impairment substantially increases aluminum retention and toxicity risk, as was documented historically in haemodialysis patients receiving aluminium-containing phosphate binders. Aluminum competes with iron at transferrin binding sites and can be transported to the brain via transferrin receptor-mediated uptake.

Elevated urinary aluminum in individuals with normal renal function indicates above-average environmental or dietary exposure. In functional and integrative medicine, aluminum is assessed in patients with unexplained cognitive symptoms, fatigue, and bone pain, and in patients with high antacid use or occupational exposure (welding, pottery, pharmaceutical manufacturing). Renal function (creatinine, eGFR) must always be assessed alongside urinary aluminum — impaired renal clearance raises urinary aluminum independently of exposure and affects the clinical interpretation of results. # REVIEWER FLAG: The association between aluminum and neurological disease (including Alzheimer's disease) is biologically plausible but not conclusively established at environmental exposure levels — reviewer to confirm appropriate interpretive framing.

Antimony is a metalloid with chemical properties similar to arsenic, existing in trivalent (Sb³⁺) and pentavalent (Sb⁵⁺) oxidation states. Primary exposure sources include flame retardants (antimony trioxide in textiles, electronics, and plastics), lead-antimony alloys in ammunition and batteries, and occupational exposure in smelting and semiconductor manufacturing. Trivalent antimony is more toxic than pentavalent and shares mechanistic toxicity with arsenic through inhibition of sulfhydryl-containing enzymes.

Urinary antimony reflects recent exposure and is assessed in functional medicine in patients with occupational or environmental exposure history, or in the context of multi-metal toxicant screening. Antimony exposure has been associated with respiratory irritation, dermatitis, and cardiovascular effects at high occupational levels. General population urinary levels are very low; elevated values without an identifiable exposure source should prompt investigation of occupational history, indoor air quality (antimony-based flame retardants in furniture, electronics), and drinking water source.

Soluble barium compounds — barium chloride, barium carbonate — are toxic; insoluble barium sulfate (used as a radiological contrast agent) is not significantly absorbed. Environmental exposure sources include barium in drinking water, food (Brazil nuts, seaweed, grains grown in barium-rich soil), and industrial processes (oil and gas drilling muds, glass manufacturing, pigment production). Barium competes with potassium at ion channels, blocking inward rectifier potassium channels and causing membrane depolarisation.

Urinary barium is included in comprehensive toxic metals panels as an exposure marker. Significant barium elevation is associated with hypokalaemia-like effects — muscle weakness, cardiac arrhythmia, and hypertension — through potassium channel blockade. In the general population, elevated urinary barium most commonly reflects dietary sources (Brazil nuts are a particularly concentrated source) or contaminated drinking water. Occupational exposure assessment and water source investigation are the primary investigative responses to elevated urinary barium in clinical practice.

Nickel is a transition metal with both essential (trace cofactor in some organisms) and toxic properties at higher human exposures. Primary exposure routes include dietary intake (legumes, nuts, chocolate, oats, and certain vegetables are nickel-rich foods), drinking water, tobacco smoke, nickel alloy implants and orthopaedic prostheses, jewellery, and occupational exposure in refining, electroplating, and stainless steel manufacturing. Nickel is excreted primarily renally. Nickel disrupts cellular signalling through epigenetic mechanisms, including inhibition of DNA repair enzymes and histone demethylases.

Nickel is the most common cause of contact dermatitis worldwide and a Group 1 IARC carcinogen in occupational settings (nasal and lung cancer in nickel refinery workers). In functional medicine, urinary nickel is assessed in patients with nickel allergy and unexplained dermatological reactions, those with metallic implants or dental work containing nickel alloys, and in comprehensive environmental toxicant screening. Dietary nickel restriction (reducing legumes, oats, chocolate, and whole grains) can meaningfully lower urinary excretion in nickel-sensitive individuals.

Thallium is a highly toxic trace element with no known biological role. It mimics potassium due to similar ionic radius and charge, substituting for potassium at sodium-potassium ATPase and other potassium-dependent transport systems, disrupting neurological, gastrointestinal, and hair follicle function. Primary exposure sources include cigarette smoke (tobacco plants bioaccumulate thallium from soil), contaminated food grown in industrially polluted soil, cement dust, and historical use in rodenticides and depilatory agents (now banned). Thallium is excreted both renally and in faeces.

Thallium toxicity produces a characteristic clinical triad of gastrointestinal symptoms, peripheral neuropathy, and alopecia — the latter resulting from thallium's disruption of keratinisation in hair follicles. In the general population, tobacco smoking is the predominant source of low-level thallium exposure. Urinary thallium is included in comprehensive toxic metal panels as an environmental exposure marker and is a clinically important element to flag when alopecia or peripheral neuropathy accompanies multi-metal burden. Elevated thallium in non-smokers warrants investigation of diet, water source, and geographic/occupational exposure history.

Uranium is a naturally occurring radioactive heavy metal present in soil, rock, and groundwater at varying concentrations depending on local geology. The primary exposure route in the general population is drinking water — particularly from private wells in granite-rich geological areas — with secondary dietary contribution from food grown in uranium-rich soil. Uranium nephrotoxicity (chemical rather than radiological) results from accumulation in proximal renal tubular cells, where it competes with iron at transferrin binding sites and impairs mitochondrial function.

Urinary uranium is a marker of environmental uranium exposure, primarily from contaminated drinking water — particularly relevant in patients using private well water in areas of known natural uranium geochemistry, near uranium mining operations, or in regions with historically elevated groundwater uranium. The primary toxicological concern is nephrotoxicity rather than radiological carcinogenicity at environmental exposure levels, though both are relevant at high exposures. Practitioners should assess drinking water source when elevated urinary uranium is identified.

Inorganic tin compounds, widely used in food can linings (tin-plated steel) and industrial coatings, are poorly absorbed from the GI tract and have low toxicity at typical dietary exposure levels. Organotin compounds — tributyltin (TBT), used historically as antifouling paint in marine applications, and tributyltin oxide — are substantially more toxic, acting as endocrine disruptors and immunotoxicants. Urinary tin reflects primarily inorganic tin exposure and recent dietary intake.

Urinary tin is included in comprehensive toxic metal panels as a completeness element. Elevated inorganic urinary tin most commonly reflects canned food consumption or industrial exposure. Organotin-specific assessment requires specialised analysis not typically included in standard ICP-MS urine metal panels. In functional medicine, tin is interpreted alongside the full panel pattern rather than as a primary clinical target.

Tungsten is a transition metal used extensively in hard metal alloys (cemented tungsten carbide), military ammunition (tungsten-based alloys as lead substitutes), electronic components, and filaments. Exposure routes include occupational inhalation in hard metal manufacturing, ingestion from contaminated water sources (elevated tungsten in groundwater has been identified in specific geographic clusters in the USA), and inhalation of gunshot residue from tungsten-based ammunition. Tungsten inhibits molybdenum-dependent enzymes by substituting for molybdenum as a cofactor analogue.

Elevated urinary tungsten in the general population is uncommon; when identified, it warrants occupational history review (hard metal machining, military service, shooting sports), water source investigation, and geographic mapping against known tungsten-contaminated water sources. Epidemiological investigations have identified geographic clusters of elevated childhood leukaemia in areas with elevated groundwater tungsten (notably Fallon, Nevada, USA), though causal attribution remains under investigation. # REVIEWER FLAG: The tungsten-leukaemia association is epidemiological and not conclusively causal — reviewer to confirm appropriate framing.

Bismuth is a heavy post-transition metal used medicinally in bismuth subsalicylate (Pepto-Bismol and equivalent products) for gastrointestinal indications, and historically in dermatological preparations. Urinary bismuth rises predictably with bismuth-containing medication use and falls rapidly on discontinuation. Occupational exposure occurs in bismuth alloy manufacturing, electronics, and cosmetics production. Bismuth is excreted renally, with a biphasic half-life following medicinal use.

Elevated urinary bismuth in clinical practice most commonly reflects recent use of bismuth-containing over-the-counter gastrointestinal medications. Bismuth subsalicylate use is the dominant confounding factor and must be documented on the requisition form. At very high therapeutic doses, bismuth encephalopathy has been described historically with prolonged high-dose use of certain bismuth preparations (no longer available in most markets). In standard functional medicine toxic metal panels, bismuth elevation is typically a medication-use finding rather than an environmental toxicant concern.